BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24137473)

  • 21. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
    Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
    Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptotic effects of Photofrin-Diomed 630-PDT on SHEEC human esophageal squamous cancer cells.
    Gao S; Zhang M; Zhu X; Qu Z; Shan T; Xie X; Wang Y; Feng X
    Int J Clin Exp Med; 2015; 8(9):15098-107. PubMed ID: 26628993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy.
    Morgan J; Jackson JD; Zheng X; Pandey SK; Pandey RK
    Mol Pharm; 2010 Oct; 7(5):1789-804. PubMed ID: 20684544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Image-guided Interstitial Photodynamic Therapy for Squamous Cell Carcinomas: Preclinical investigation.
    Sajisevi M; Rigual NR; Bellnier DA; Seshadri M
    J Oral Maxillofac Surg Med Pathol; 2015 Mar; 27(2):159-165. PubMed ID: 25750858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX.
    Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Dougherty TJ
    Lasers Surg Med; 2006 Jun; 38(5):439-44. PubMed ID: 16634075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Explicit dosimetry for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a-mediated photodynamic therapy: macroscopic singlet oxygen modeling.
    Penjweini R; Liu B; Kim MM; Zhu TC
    J Biomed Opt; 2015; 20(12):128003. PubMed ID: 26720883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetic modeling and simulation of HPPH in Chinese patients with esophageal carcinoma.
    Chen L; Ye X; Hu K; Zhai Y; Li W; Wang X; Yang J
    Xenobiotica; 2020 Feb; 50(2):170-177. PubMed ID: 30901299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts.
    Sine J; Urban C; Thayer D; Charron H; Valim N; Tata DB; Schiff R; Blumenthal R; Joshi A; Puri A
    Int J Nanomedicine; 2015; 10():125-45. PubMed ID: 25565809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The In Vitro and In Vivo Anticancer Effect of Photomed for Photodynamic Therapy: Comparison with Photofrin and Radachlorin.
    Kim J; Kim J; Yoon H; Chae YJ; Rhew K; Chang JE
    Curr Issues Mol Biol; 2023 Mar; 45(3):2474-2490. PubMed ID: 36975532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conjugation of 2-(1'-hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo.
    Zheng X; Morgan J; Pandey SK; Chen Y; Tracy E; Baumann H; Missert JR; Batt C; Jackson J; Bellnier DA; Henderson BW; Pandey RK
    J Med Chem; 2009 Jul; 52(14):4306-18. PubMed ID: 19507863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2.
    Liu W; Baer MR; Bowman MJ; Pera P; Zheng X; Morgan J; Pandey RA; Oseroff AR
    Clin Cancer Res; 2007 Apr; 13(8):2463-70. PubMed ID: 17438106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Advances in the HPPH-Based Third-Generation Photodynamic Agents in Biomedical Applications.
    Fan L; Jiang Z; Xiong Y; Xu Z; Yang X; Gu D; Ainiwaer M; Li L; Liu J; Chen F
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of ephrin-A1 on resistance to Photofrin-mediated photodynamic therapy in esophageal squamous cell carcinoma cells.
    Yang PW; Chiang TH; Hsieh CY; Huang YC; Wong LF; Hung MC; Tsai JC; Lee JM
    Lasers Med Sci; 2015 Dec; 30(9):2353-61. PubMed ID: 26450615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative tumor imaging and PDT Efficacy of HPPH conjugated in the mono- and di-forms to various polymethine cyanine dyes: part - 2.
    James NS; Ohulchanskyy TY; Chen Y; Joshi P; Zheng X; Goswami LN; Pandey RK
    Theranostics; 2013; 3(9):703-18. PubMed ID: 24019855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo spectroscopic evaluation of human tissue optical properties and hemodynamics during HPPH-mediated photodynamic therapy of pleural malignancies.
    Morales RDH; Hong Ong Y; Finlay J; Dimofte A; Simone CB; Friedberg JS; Busch TM; Cengel KA; Zhu TC
    J Biomed Opt; 2022 Oct; 27(10):. PubMed ID: 36316298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Codelivery of Anticancer Drug and Photosensitizer by PEGylated Graphene Oxide and Cell Penetrating Peptide Enhanced Tumor-Suppressing Effect on Osteosarcoma.
    Zhang YF; Wu YF; Lan TJ; Chen Y; Su SH
    Front Mol Biosci; 2020; 7():618896. PubMed ID: 33898510
    [No Abstract]   [Full Text] [Related]  

  • 37. Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice.
    Gil M; Bieniasz M; Seshadri M; Fisher D; Ciesielski MJ; Chen Y; Pandey RK; Kozbor D
    Br J Cancer; 2011 Nov; 105(10):1512-21. PubMed ID: 21989183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models.
    Shi R; Li C; Jiang Z; Li W; Wang A; Wei J
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28085075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment and comparison of three novel methods for the determination of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in human serum.
    Chen L; Xiao Q; Zhang X; Yang J
    J Pharm Biomed Anal; 2016 Mar; 121():13-21. PubMed ID: 26773535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photosensitizer (PS)-cyanine dye (CD) conjugates: Impact of the linkers joining the PS and CD moieties and their orientation in tumor-uptake and photodynamic therapy (PDT).
    James NS; Joshi P; Ohulchanskyy TY; Chen Y; Tabaczynski W; Durrani F; Shibata M; Pandey RK
    Eur J Med Chem; 2016 Oct; 122():770-785. PubMed ID: 27543778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.